Effects of Systemic Drugs on Intraocular Pressure

NCT05328921 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2022-04-14

No results posted yet for this study

Summary

To assess intraocular pressure changes among glaucoma patients on systemic antihypertensive and antihistaminic drugs.

Conditions

  • Glaucoma, Angle-Closure
  • Glaucoma Suspect
  • Glaucoma Secondary to Drugs, Bilateral
  • Hypertension

Interventions

DRUG

Antihypertensive Agents

Patients with narrow angle glaucoma and on systemic antihypertensive drugs.

DRUG

Antihistaminics

Patients with narrow angle glaucoma and on systemic antihistaminic drugs.

Sponsors & Collaborators

  • Benha University

    lead OTHER

Eligibility

Min Age
35 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-04-07
Primary Completion
2022-09-15
Completion
2022-09-30

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05328921 on ClinicalTrials.gov